Danon disease – dysregulation of autophagy in a multisystem disorder with cardiomyopathy
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Danon disease is a rare, severe X-linked form of cardiomyopathy caused by deficiency of lysosome-associated membrane protein 2 (LAMP-2). Other clinical manifestations include skeletal myopathy, cognitive defects and visual problems. Although individuals with Danon disease have been clinically described since the early 1980s, the underlying molecular mechanisms involved in pathological progression remain poorly understood. LAMP-2 is known to be involved in autophagy, and a characteristic accumulation of autophagic vacuoles in the affected tissues further supports the idea that autophagy is disrupted in this disease. The LAMP2 gene is alternatively spliced to form three splice isoforms, which are thought to play different autophagy-related cellular roles. This Commentary explores findings from genetic, histological, functional and tissue expression studies that suggest that the specific loss of the LAMP-2B isoform, which is likely to be involved in macroautophagy, plays a crucial role in causing the Danon phenotype. We also compare findings from mouse and cellular models, which have allowed for further molecular characterization but have also shown phenotypic differences that warrant attention. Overall, there is a need to better functionally characterize the LAMP-2B isoform in order to rationally explore more effective therapeutic options for individuals with Danon disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Role of Atg Proteins in Autophagosome Formation
Mizushima, N., Yoshimori, T., & Ohsumi, Y. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154005 · Cited by 2,978
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
Nishino, I., Fu, J., Tanji, K., Yamada, T., Shimojo, S., Koori, T., Mora, M., Riggs, J. E., Oh, S. J., Koga, Y., et al. (2000) · Nature · doi:10.1038/35022604 · Cited by 959 · cited 1×
“For reviews discussing other diseases that share clinical similarities with Danon disease, including Pompe disease, Niemann-Pick type C and other lysosomal storage diseases, see Ruivo et al. (2009), D’souza et al. (2014) and Pastores and Hughes (2015).”
BackgroundAccumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice
Tanaka, Y., Guhde, G., Suter, A., Eskelinen, E.-L., Hartmann, D., Lüllmann-Rauch, R., Janssen, P. M. L., Blanz, J., von Figura, K., & Saftig, P. (2000) · Nature · doi:10.1038/35022595 · Cited by 925
Methods for Monitoring Autophagy from Yeast to Human
Klionsky, D. J., Cuervo, A. M., & Seglen, P. O. (2007) · Autophagy · doi:10.4161/auto.3678 · Cited by 656
Maturation of Autophagic Vacuoles in Mammalian Cells
Eskelinen, E.-L. (2005) · Autophagy · doi:10.4161/auto.1.1.1270 · Cited by 626
Consequences of the selective blockage of chaperone-mediated autophagy
Massey, A. C., Kaushik, S., Sovak, G., Kiffin, R., & Cuervo, A. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507436103 · Cited by 529 · cited 2×
“Overall, the LAMP1-knockout mouse phenotype is relatively mild (Eskelinen, 2006), and although there might be shared functions between LAMP-1 and LAMP-2, LAMP1 levels have not been found to increase to compensate for blockage of CMA, which is the best characterized function of LAMP-2 (Massey et al., 2006), nor does tr…”
BackgroundGibbs, D., Kitamoto, J., & Williams, D. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1130432100 · Cited by 250
Kuma, A., & Mizushima, N. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2010.03.002 · Cited by 237 · cited 1×
“…mitochondria, ribosomes, peroxisomes, endoplasmic reticulum and additional membrane structures, glycogen, lipid granules and other cytosolic aggregates (Kovsan et al., 2010; Kundu et al., 2008; Kuma and Mizushima, 2010; Schneider and Cuervo, 2014; Shires and Gustafsson, 2015; Nishida et al., 2015).”
BackgroundCone-rod dystrophy can be a manifestation of Danon disease
Thiadens, A. A. H. J., Slingerland, N. W. R., Florijn, R. J., Visser, G. H., Riemslag, F. C., & Klaver, C. C. W. (2012) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1857-8 · Cited by 36 · cited 1×
“…POS-based vesicles (i.e. phagosomes) into the cell (Gibbs et al., 2003) – as well as proteins and proteases (e.g. βA3-crystallin, A1-crystallin and cathepsin D) that are involved in lysosomal degradation following fusion of the phagosome with the lysosome (Nandrot, 2014; Valapala et al., 2016).”
Background
Cited by
Khandia, R., Dadar, M., Munjal, A., Dhama, K., Karthik, K., Tiwari, R., Yatoo, M. I., Iqbal, H. M. N., Singh, K. P., Joshi, S. K., et al. (2019) · Cells · doi:10.3390/cells8070674 · Cited by 314
Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets
Dewanjee, S., Das, S., Das, A. K., Bhattacharjee, N., Dihingia, A., Dua, T. K., Kalita, J., & Manna, P. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.034 · Cited by 300
Cui, L., Zhao, L.-P., Ye, J.-Y., Yang, L., Huang, Y., Jiang, X.-P., Zhang, Q., Jia, J.-Z., Zhang, D.-X., & Huang, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00031 · Cited by 62
“Humans with Danon disease and Lamp2-knockout mice both show hypertrophic cardiomyopathy characterized by accumulated autophagic vacuoles filled with polymorphic contents, which are mainly the result of disrupted macroautophagy (Tanaka et al., 2000; Rowland et al., 2016).”
BackgroundUpdate review about metabolic myopathies
Finsterer, J. (2020) · Life · doi:10.3390/life10040043 · Cited by 31
“Thus, LAMP2 deficiency leads to failure and disturbance of macroautophagy [78].”
Background
Metadata
- Authors
- Rowland, T. J., Sweet, M. E., Mestroni, L., & Taylor, M. R. G.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2016-06-01
- Volume
- 129
- Issue
- 11
- Pages
- 2135-2143
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2382399754
- Cited by
- 97
- References
- 9
- FWCI
- 8.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.